Daparyl M 5mg/500mg Tablet ER
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Dapagliflozin (5mg) + Metformin (500mg)
Overview Daparyl M 5mg/500mg Tablet ER
Metformin/glimepiride extended-release tablets (5mg/500mg) are prescribed for managing type 2 diabetes. This dual-action medication regulates elevated blood glucose, mitigating the risk of severe diabetic complications and cardiovascular events. Daparyl M 5mg/500mg ER tablets can be ingested with meals; consistent daily dosing enhances adherence. Dosage is determined by your physician; discontinuation requires medical consultation to avoid potential hyperglycemia and complications such as renal impairment or vision loss. This medication forms part of a comprehensive diabetes management plan encompassing diet modification, physical activity, and weight management as directed by your healthcare provider. Commonly reported side effects include upper respiratory symptoms (sore throat, nasal congestion, rhinorrhea), headache, gastrointestinal upset (nausea, vomiting, diarrhea). Adequate hydration minimizes dehydration risk. Genital yeast infections may occur; diligent hygiene practices are recommended. Prior to commencing therapy, inform your doctor about pre-existing kidney or liver disease, urinary tract infections, diuretic use, or pregnancy/breastfeeding. Limit alcohol consumption to reduce potential side effects. Regular blood glucose monitoring is essential during treatment.
Primary Ingredients of Daparyl M 5mg/500mg Tablet ER
No information provided. Please provide the text you wish to be rephrased.
Uses of Daparyl M 5mg/500mg Tablet ER
Managing type 2 diabetes
Major Benefits of Daparyl M 5mg/500mg Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Daparyl M 5mg/500mg Extended-Release tablet should be taken with a meal.
Common Side effects of Daparyl M 5mg/500mg Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Daparyl M 5mg/500mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Daparyl M 5mg/500mg Extended-Release tablet whole; avoid crushing, chewing, or breaking it. Administer this medicine with a meal.
How Daparyl M 5mg/500mg Tablet ER works:
The extended-release tablet, Daparyl M 5mg/500mg, combines dapagliflozin and metformin to manage type 2 diabetes. Dapagliflozin facilitates glucose excretion via the kidneys, while metformin reduces hepatic glucose production, slows intestinal glucose uptake, and enhances insulin responsiveness. This dual action leads to improved glycemic control.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use and Daparyl M 5mg/500mg Tablet ER is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Daparyl M 5mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Daparyl M 5mg/500mg tablets are likely unsafe for breastfeeding mothers. Scant human evidence indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Caution is advised when prescribing Daparyl M 5mg/500mg Extended-Release tablets to individuals with impaired renal function. Dosage modifications for Daparyl M 5mg/500mg Extended-Release tablets may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with hepatic impairment should use Daparyl M 5mg/500mg Extended-Release tablets cautiously; dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Daparyl M 5mg/500mg Tablet ER :
Should you forget a Daparyl M 5mg/500mg Extended-Release Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Daparyl M 5mg/500mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Treatment |






